Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

Semaglutide

Semaglutide is an acylated GLP-1 analogue with a long half-life. It is the best-characterised incretin peptide in the research literature and an approved prescription medicine.

Approved prescription medicineMetabolic & incretin researchLong-acting GLP-1 receptor agonist5/55/5

At a glance

5/55/5
Class
GLP-1 receptor agonist
Receptor targets
GLP-1R
Length
31 amino acids (acylated GLP-1 analogue)
Molecular mass
≈ 4.11 kDa
Origin
Synthetic analogue of human GLP-1
Research area
Metabolic & incretin research
Also known as
–

What Semaglutide is

Semaglutide is a modified version of human GLP-1. Two changes make it durable: an amino-acid substitution that resists breakdown by the enzyme DPP-4, and a fatty-acid side chain that lets it bind albumin in blood. Together they extend its half-life from minutes to about a week in clinical use.

Because it acts on a single receptor, GLP-1, it is the usual reference point when researchers compare newer multi-receptor peptides such as tirzepatide and retatrutide.

What the research literature studies

  • GLP-1 receptor binding and cAMP signalling in cell-based assays
  • Incretin biology: how GLP-1R activity differs from dual and triple agonism
  • Albumin binding and the effect of fatty-acid acylation on peptide stability

Evidence rating: 5/5

Approved drug, phase 3 trials. Approved medicine backed by large randomised phase 3 programmes. See our methodology for how levels are assigned.

  • Almost all outcome data come from the branded medicine, not from research-grade material.
  • Analytical identity (intact mass, related substances) matters more than headline purity for a modified peptide.

Regulatory status

Semaglutide is authorised as a prescription medicine by the MHRA, EMA and FDA under several brand names. Laboratory research material is not that medicine, is not evaluated by any regulator, and must not be used in people or animals.

Reviewed November 2026.

Semaglutide at Nordapep: sizes and price per mg

Every size, its price and the cost per milligram, so you can choose the best-value vial for your protocol.

Not currently listed at Nordapep.

Compare Semaglutide

Semaglutide FAQ

How does semaglutide differ from tirzepatide?

Semaglutide activates the GLP-1 receptor only. Tirzepatide activates both the GLP-1 and GIP receptors. See the side-by-side comparison for structure, evidence level and regulatory status.

Is semaglutide a peptide or a protein?

A peptide. At about 31 amino acids plus a fatty-acid side chain it is far smaller than a protein.

Where can I buy Semaglutide for research?

Nordapep does not currently list Semaglutide. You can ask Nordapep about availability, or compare related compounds that are in stock.

Is Semaglutide approved?

Semaglutide is authorised as a prescription medicine by the MHRA, EMA and FDA under several brand names. Laboratory research material is not that medicine, is not evaluated by any regulator, and must not be used in people or animals.

Key terms for Semaglutide

Further reading

Cite this page

peptide.wiki. (2026). Semaglutide: research peptide profile. peptide.wiki. https://www.peptide.wiki/peptides/semaglutide
Free to cite and link. Last reviewed November 2026.
For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.

Related compounds